RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial.
Theresa LinkJens-Uwe BlohmerWolfgang Daniel SchmittJan Dominik KuhlmannMarianne JustMichael UntchOliver StotzerPeter Andreas FaschingMarc ThillMattea ReinischAndreas SchneeweißPauline WimbergerSabine SeilerJens HuoberChristian JackischKerstin RhiemClaus HanuschBruno Valentin SinnValentina NekljudovaSibylle LoiblCarsten DenkertPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
We report RANK expression to be an independent predictive biomarker for response to NACT in luminal-like breast cancer patients.